Skip to content

The comparison of different insering time on patients under remazolam combined with remifentanil anesthesia in Gastroscopy

The comparison of different insering time on patients under remazolam combined with remifentanil anesthesia in Gastroscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127712
Enrollment
Unknown
Registered
2026-07-06
Start date
2024-05-07
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digestive tract diseases

Interventions

Regular Group:Try inserting the gastroscope after the eyelash reflex disappears
experimental group:Try inserting the gastroscope once the patient no longer shows any movement response to pressure on the jaw, that is, after losing any movement from jaw pressure.

Sponsors

The First People’s Hospital of Huizhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-60 years old; 2. ASA grade I-II; 3. Body mass index 25-30 kg/m^2; 4. Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. People who are allergic to remimazolam or remifentanil; 2. Body mass index > 31 kg/m^2; 3. Obstructive sleep apnea syndrome, acute upper respiratory tract infection, or acute rhinitis; 4. History of tracheostomy or difficult intubation; 5. People with anemia, thrombocytopenia, or abnormal liver or kidney function; 6. Suspected gastrointestinal lesions requiring complex or therapeutic endoscopy; 7. Long-term use of sedatives or painkillers, mental illness, or neurological disorders; 8. Pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
Camera satisfaction;Side effects;

Countries

China

Contacts

Public ContactHuang zhuomei

The First People’s Hospital of Huizhou

huangzhuomei316@163.com+86 752 288 3630

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026